Teva Pharmaceutical Industries (TEVA) EBIT Growth (1y) (2010 - 2026)
Powered by 
Analysis
Teva Pharmaceutical Industries (TEVA) EBIT Growth (1y) (2010 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | -150.77% |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | -97.30% |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | -80.43% |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 16.52% |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 66.67% |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 191.25% |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | - |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | -5.82% |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 163.58% |
| 10 | NutriBand | 72.57 Mn | 69.15 Mn | 181,874.00 | 55.54% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -150.77% |
| Mar 31, 2026 | 25.63% |
| Dec 31, 2025 | 1,134.48% |
| Sep 30, 2025 | 1,829.41% |
| Jun 30, 2025 | 9,200.00% |
| Mar 31, 2025 | 338.07% |
| Dec 31, 2024 | -103.84% |
| Sep 30, 2024 | -114.83% |
| Jun 30, 2024 | 99.24% |
| Mar 31, 2024 | -1,576.92% |
| Dec 31, 2023 | 180.43% |
| Sep 30, 2023 | -18.87% |
| Jun 30, 2023 | 32.37% |
| Mar 31, 2023 | 98.18% |
| Dec 31, 2022 | -1,305.13% |
| Sep 30, 2022 | -31.94% |
| Jun 30, 2022 | -266.15% |
| Mar 31, 2022 | -264.29% |
| Dec 31, 2021 | -80.79% |
| Sep 30, 2021 | 114.35% |